Study checks how well standard leukemia treatment works in real patients
NCT ID NCT06362044
Summary
This study looked at how well a standard treatment combination works for Japanese adults with relapsed chronic lymphocytic leukemia (CLL) in real-world clinics. It followed 89 patients who took venetoclax pills, with or without rituximab infusions, for two years. The main goal was to see how many patients achieved a state of 'undetectable' cancer cells in their blood after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center Hospital East /ID# 265970
Kashiwa-shi, Chiba, 277-8577, Japan
Conditions
Explore the condition pages connected to this study.